Published on

Medicine – AIDS-Defining Illnesses (Indicator Diseases for AIDS)

Acquired immunodeficiency syndrome (AIDS) represents advanced HIV infection characterised by severe immune dysfunction and increased susceptibility to opportunistic infections, malignancies and neurological complications.

An AIDS diagnosis may be established when a person with HIV develops a recognised AIDS-defining illness, regardless of CD4 count.

Under the commonly used US CDC surveillance definition, a CD4 count below 200 cells/mm³ or a CD4 percentage below 14% also meets the immunological criteria for AIDS.

Important Clinical Principle

AIDS is not defined solely by the CD4 count. A recognised AIDS-defining illness may establish the diagnosis even when the CD4 count is above 200 cells/mm³.

The exact list of indicator diseases varies slightly between classification systems, including CDC and WHO definitions. This article primarily follows CDC terminology, with relevant paediatric distinctions.

1. Overview of AIDS-Defining Illnesses

HIV Infection Progressive Immune Dysfunction Increased susceptibility to disease AIDS-Defining Conditions Opportunistic Infections Malignancies Neurological Conditions Wasting and Systemic Disease

2. AIDS-Defining Respiratory Infections

A. Recurrent Bacterial Pneumonia

Recurrent bacterial pneumonia is an AIDS-defining condition in adults and adolescents when there are two or more episodes within one year, according to CDC criteria.

Common Organisms

  • Streptococcus pneumoniae.
  • Haemophilus influenzae.
  • Staphylococcus aureus.

Clinical Features

  • Fever.
  • Productive cough.
  • Dyspnoea.
  • Pleuritic chest pain.
  • Pulmonary consolidation.
Examination Point: A single episode of bacterial pneumonia is not necessarily AIDS-defining. Recurrent episodes meeting the specified criteria are.

B. Oesophageal or Pulmonary Candidiasis

Candidiasis is caused by Candida species, most commonly Candida albicans.

AIDS-Defining Presentations

  • Oesophageal candidiasis.
  • Candidiasis of the bronchi.
  • Tracheal candidiasis.
  • True pulmonary candidiasis.

Oesophageal candidiasis typically causes:

  • Odynophagia.
  • Dysphagia.
  • Retrosternal discomfort.

Oral candidiasis alone is not AIDS-defining.

True Candida pneumonia is extremely rare. Candida detected in respiratory secretions usually represents colonisation rather than invasive pulmonary infection.

Examination Point: Oesophageal candidiasis is AIDS-defining, but uncomplicated oral thrush is not.

C. Pneumocystis jirovecii Pneumonia (PCP)

Previously called Pneumocystis carinii pneumonia, PCP is caused by the fungus Pneumocystis jirovecii.

It typically occurs when the CD4 count is below 200 cells/mm³.

Clinical Features

  • Progressive dyspnoea.
  • Dry cough.
  • Fever.
  • Hypoxaemia.
  • Bilateral diffuse pulmonary infiltrates or ground-glass opacities.

Treatment

First-line treatment is high-dose co-trimoxazole (trimethoprim-sulfamethoxazole).

Adjunctive corticosteroids are indicated in moderate-to-severe PCP with significant hypoxaemia.

Examination Point: PCP is an AIDS-defining illness classically associated with CD4 counts below 200 cells/mm³.

D. Mycobacterial Infections

AIDS-defining mycobacterial infections include:

  • Pulmonary tuberculosis.
  • Extrapulmonary tuberculosis.
  • Disseminated Mycobacterium avium complex (MAC).
  • Disseminated infection with certain other nontuberculous mycobacteria.

Tuberculosis

Pulmonary tuberculosis is AIDS-defining under CDC criteria for adults and adolescents with HIV.

TB can occur at any CD4 count.

Clinical features include persistent cough, fever, night sweats, weight loss and fatigue.

Advanced HIV may produce atypical chest radiographs and increase the likelihood of extrapulmonary or disseminated TB.

Mycobacterium avium Complex

Disseminated MAC is classically associated with CD4 counts below 50 cells/mm³.

Clinical features include fever, weight loss, diarrhoea, abdominal pain, lymphadenopathy and anaemia.

Examination Point: TB can occur at any CD4 count, whereas disseminated MAC is strongly associated with advanced immunosuppression.

3. AIDS-Defining Malignancies

A. Kaposi Sarcoma

Kaposi sarcoma is a vascular tumour associated with human herpesvirus 8 (HHV-8).

Clinical Features

  • Violaceous or reddish-brown skin lesions.
  • Oral mucosal lesions.
  • Gastrointestinal involvement.
  • Pulmonary involvement.
  • Lymphadenopathy in some cases.

Illustration: Kaposi Sarcoma Skin Lesions

Schematic illustration of violaceous Kaposi sarcoma lesions.

View clinical photographs of Kaposi sarcoma
Examination Point: Kaposi sarcoma is an HHV-8-associated AIDS-defining malignancy characterised by violaceous lesions.

B. Invasive Cervical Carcinoma

Invasive cervical carcinoma is associated with persistent infection by high-risk human papillomavirus (HPV) types.

It is an AIDS-defining malignancy under CDC criteria.

Important distinction: Cervical intraepithelial neoplasia is not itself AIDS-defining; invasive cervical carcinoma is.

C. AIDS-Defining Lymphomas

An important additional group of AIDS-defining malignancies consists of certain HIV-associated lymphomas.

Examples

  • Diffuse large B-cell lymphoma.
  • Burkitt lymphoma.
  • Primary CNS lymphoma.
  • Primary effusion lymphoma.

Hodgkin lymphoma is associated with HIV but is not classified as AIDS-defining under CDC criteria.

4. AIDS-Defining Viral Infections

A. Cytomegalovirus (CMV) Disease

CMV disease commonly occurs in patients with advanced immunosuppression, particularly when the CD4 count is below 50 cells/mm³.

Clinical Manifestations

  • CMV retinitis.
  • CMV colitis.
  • CMV oesophagitis.
  • Other qualifying organ disease.

CMV retinitis may cause floaters, blurred vision and progressive visual loss.

CMV disease involving organs other than the liver, spleen or lymph nodes is AIDS-defining under CDC criteria when onset occurs after the neonatal period.

Examination Point: CMV retinitis is an AIDS-defining illness strongly associated with CD4 counts below 50 cells/mm³.

B. Herpes Simplex Virus (HSV) Infection

HSV may cause mucocutaneous and visceral disease in patients with advanced HIV.

AIDS-Defining Manifestations

  • Chronic mucocutaneous ulcers lasting longer than one month.
  • HSV bronchitis.
  • HSV pneumonitis.
  • HSV oesophagitis.

A short, uncomplicated episode of oral or genital herpes is not AIDS-defining.

Examination Point: Chronic HSV mucocutaneous ulcers must persist for more than one month to meet the AIDS-defining criterion.

5. AIDS-Defining Parasitic and Fungal Infections

A. Cerebral Toxoplasmosis

Cerebral toxoplasmosis is caused by Toxoplasma gondii and typically occurs when the CD4 count is below 100 cells/mm³.

Clinical Features

  • Headache.
  • Fever.
  • Seizures.
  • Focal neurological deficits.
  • Altered consciousness.

Brain imaging often demonstrates multiple ring-enhancing lesions, frequently involving the basal ganglia.

Illustration: Ring-Enhancing Brain Lesions

Ring lesion

Schematic illustration of multiple ring-enhancing brain lesions.

View real cerebral toxoplasmosis MRI images
Examination Point: Cerebral toxoplasmosis commonly causes multiple ring-enhancing brain lesions in patients with CD4 counts below 100 cells/mm³.

B. Cryptococcosis

Cryptococcosis is caused primarily by Cryptococcus neoformans, an encapsulated yeast.

It commonly presents as subacute meningitis in advanced HIV.

Clinical Features

  • Headache.
  • Fever.
  • Raised intracranial pressure.
  • Altered mental status.

Extrapulmonary cryptococcosis is AIDS-defining.

Isolated pulmonary cryptococcosis is not automatically AIDS-defining under CDC criteria.

C. Cryptosporidiosis

Cryptosporidium causes watery diarrhoea and malabsorption.

Clinical Features

  • Persistent watery diarrhoea.
  • Abdominal discomfort.
  • Dehydration.
  • Weight loss.
  • Malabsorption.

Intestinal cryptosporidiosis lasting more than one month is AIDS-defining.

D. Isosporiasis (Cystoisosporiasis)

The organism previously called Isospora belli is now known as Cystoisospora belli.

It causes persistent watery diarrhoea, weight loss and malabsorption.

Intestinal isosporiasis lasting more than one month is AIDS-defining.

Examination Point: Both cryptosporidiosis and cystoisosporiasis are AIDS-defining when intestinal disease persists for more than one month.

E. Disseminated Histoplasmosis

Histoplasmosis is caused by Histoplasma capsulatum.

Disseminated or extrapulmonary histoplasmosis is AIDS-defining.

Clinical Features

  • Prolonged fever.
  • Weight loss.
  • Hepatosplenomegaly.
  • Lymphadenopathy.
  • Cytopenias.

F. Disseminated Coccidioidomycosis

Coccidioidomycosis is caused by Coccidioides species.

Disseminated or extrapulmonary disease is AIDS-defining.

Possible Sites

  • Meninges.
  • Skin.
  • Bones.
  • Other internal organs.

6. AIDS-Defining Neurological Conditions

A. HIV Encephalopathy

HIV encephalopathy, historically called AIDS dementia complex, results from HIV-associated central nervous system dysfunction.

Clinical Features

  • Progressive cognitive impairment.
  • Psychomotor slowing.
  • Behavioural changes.
  • Motor dysfunction.
  • Functional deterioration.

Not every form of HIV-associated neurocognitive impairment qualifies as AIDS-defining encephalopathy.

B. Progressive Multifocal Leukoencephalopathy (PML)

PML is a demyelinating disease caused by reactivation of the JC polyomavirus.

Clinical Features

  • Progressive focal neurological deficits.
  • Visual disturbances.
  • Cognitive impairment.
  • Weakness.
  • Ataxia.

MRI commonly demonstrates asymmetric white-matter lesions with little mass effect.

The principal treatment is immune restoration through effective ART.

Examination Point: PML is caused by JC polyomavirus and produces progressive demyelinating white-matter disease.

7. AIDS Wasting Syndrome

AIDS wasting syndrome involves involuntary weight loss of more than 10% of baseline body weight, together with chronic diarrhoea or prolonged weakness and documented fever, in the absence of another explanatory illness.

Contributing Factors

  • Reduced nutritional intake.
  • Malabsorption.
  • Chronic inflammation.
  • Increased metabolic demands.
Examination Point: Weight loss alone is insufficient to meet the formal AIDS wasting syndrome definition.

8. Recurrent Non-Typhoidal Salmonella Septicaemia

Recurrent septicaemia caused by non-typhoidal Salmonella species is an AIDS-defining condition.

Clinical Features

  • Fever.
  • Chills.
  • Hypotension.
  • Systemic toxicity.
  • Recurrent bloodstream infections.

The defining feature is recurrent bloodstream infection rather than uncomplicated Salmonella gastroenteritis.

9. Lymphoid Interstitial Pneumonitis in Children

Lymphoid interstitial pneumonitis (LIP), sometimes associated with pulmonary lymphoid hyperplasia, may occur in children with HIV.

Clinical Features

  • Chronic cough.
  • Tachypnoea.
  • Hypoxaemia.
  • Diffuse interstitial pulmonary infiltrates.

This condition is included in paediatric AIDS surveillance definitions, particularly for children younger than 13 years.

It is not generally used as an adult AIDS-defining condition.

10. Comparison of AIDS-Defining Illnesses

AIDS-Defining Illness Important Diagnostic Clue
Recurrent bacterial pneumoniaAt least two episodes within one year
Oesophageal candidiasisDysphagia and odynophagia
PCPDry cough, dyspnoea, hypoxaemia; CD4 often below 200
TuberculosisCan occur at any CD4 count
Disseminated MACCD4 often below 50
Kaposi sarcomaHHV-8-associated violaceous lesions
CMV diseaseRetinitis or qualifying visceral disease
Chronic HSV infectionUlcers lasting over one month or visceral HSV disease
Cerebral toxoplasmosisRing-enhancing brain lesions
Extrapulmonary cryptococcosisCryptococcal meningitis
CryptosporidiosisDiarrhoea lasting over one month
CystoisosporiasisDiarrhoea lasting over one month
HIV encephalopathyProgressive cognitive and motor dysfunction
PMLJC virus-associated demyelination
AIDS wasting syndromeMore than 10% weight loss plus additional defining features
Invasive cervical carcinomaHPV-associated invasive malignancy
Recurrent Salmonella septicaemiaRecurrent non-typhoidal bloodstream infection
Disseminated histoplasmosisSystemic fungal infection
Disseminated coccidioidomycosisExtrapulmonary fungal disease
Paediatric LIPChronic interstitial lung disease in a child
AIDS-defining lymphomaCertain aggressive B-cell lymphomas

11. CD4 Count Associations

The CD4 count helps estimate the risk of particular opportunistic infections, but these associations are not strict diagnostic thresholds.

Typical CD4 Associations Any CD4 Count Tuberculosis; bacterial pneumonia CD4 Below Approximately 200 Pneumocystis pneumonia CD4 Below Approximately 100 Cerebral toxoplasmosis; cryptococcosis CD4 Below Approximately 50 CMV disease; disseminated MAC

Approximate clinical associations rather than strict diagnostic thresholds.

12. High-Yield Examination Summary

  • PCP: CD4 commonly below 200 cells/mm³.
  • Cerebral toxoplasmosis: CD4 commonly below 100 cells/mm³.
  • CMV disease and disseminated MAC: CD4 commonly below 50 cells/mm³.
  • Tuberculosis: Can occur at any CD4 count.
  • Chronic HSV ulcers: Must persist for more than one month to meet the mucocutaneous criterion.
  • Cryptosporidiosis and isosporiasis: Intestinal disease lasting more than one month.
  • Kaposi sarcoma: Associated with HHV-8.
  • PML: Caused by JC polyomavirus.
  • Invasive cervical carcinoma: AIDS-defining; cervical dysplasia alone is not.
  • Oral candidiasis alone: Not AIDS-defining.
  • Recurrent bacterial pneumonia: Two or more episodes within one year.
  • HIV wasting syndrome: More than 10% weight loss with additional clinical criteria.
  • AIDS-defining lymphomas: Include certain aggressive B-cell lymphomas.
Most Important Examination Point

AIDS is not defined solely by the CD4 count. A recognised AIDS-defining illness can establish the diagnosis even when the CD4 count is above 200 cells/mm³. The exact qualifying conditions and age-specific criteria depend on the classification system being used.

Clinical Note

This article is intended for medical education and examination revision. AIDS surveillance definitions are not substitutes for clinical assessment. Diagnostic criteria, treatment decisions and classification may vary by country and guideline.

Kembara Xtra – Medicine Revision Notes

Image description
0 Comments